Cancer cases in the US continued to be underdiagnosed during the second year of the COVID-19 pandemic

Researchers examine how the COVID-19 pandemic affected cancer diagnosis rates between 2021 and 2020.

Addressing local dynamics in rubella vaccination policy

When public health officials make policies about when and how vaccination programs are implemented, they must weigh the benefits and risks of how infectious diseases

May 29, 2024

Royalty Pharma’s milestone payment to Arrowhead; Abeona’s $75M offering

Plus, news about Soleno, Novo Nordisk and Cardior Pharmaceuticals: Royalty Pharma pays Arrowhead Pharmaceuticals: The $50 million milestone payment comes after the completed enrollment of a

May 4, 2024

Pfizer sets sights on Summit’s bispecific in combo with its ADCs – Pharmaceutical Technology

Pfizer and Summit did not disclose terms of the deal. Credit: ArLawKa AungTun via Getty Images. Pfizer has signed a deal with Summit Therapeutics to

February 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.